Answer
The safety and efficacy of rozanolixizumab have not been established in children and adolescents under 18 years, and no data are available.
Sources for this answer
- Rystiggo 140 mg/ml solution for injectionUCB Pharma Limited · emc · SmPC §4.2 Posology and method of administration · Version 7Document updated
Sources checked